J&J unit to start mid-stage COVID-19 vaccine trials in Spain
BARCELONA - Johnson & Johnson's Janssen unit will begin mid-stage trials of its COVID-19 vaccine in Spain on Monday, the programme's lead investigator said.
Alberto Borobia said 190 people would take part in the country's trials, which will take place in three hospitals and be concluded by Sept. 22.
The Spanish study is part of mid-stage, or Phase II, trials of the vaccine that are being carried out in three countries, also including the Netherlands and Germany.
The trials in the three countries will last two months and include 550 participants in total.
Read also
Read More
Lazy pressing, bad fitness, says Mourinho after Spurs defeat
Striker Harry Kane barely had a sight of goal, although he was not helped by a midfield lacking imagination.
Read More
Facebook removes posts linking Oregon wildfires to activist groups
Flames have destroyed thousands of homes in days, making Oregon the latest epicenter in a larger summer outbreak of fires sweeping the western United States.
Read More
Czech Republic sees record rise in virus cases for third day
The country was one of the first in Europe to mandate wearing masks, shut schools and retail businesses, and restricted travel to contain the spread of the virus.